Financials
Financial year 2025
Trimedy from Arendonk, company number BE1003419468, closed financial year 2025 with a result of € 13,632 after tax. For that financial year Trimedy recorded a gross margin of € 212,124 and equity of € 14,785. Compared with financial year 2024, the result moved from € 1,153 to € 13,632. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 14,785
▲ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13,632
▲ € 12,479 vs 2024
Profit after tax over the fiscal year.
€ 39,338
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 4,785.
People and assets in 2025
€ 173,590
▲ 13% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 20,418
▲ € 19,157 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 116,641
▲ 17% vs 2024
€ 6,516 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.
€ 100,107
▲ 158% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 31,331
▲ 65% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 164,617 | € 212,124 | ▲ 29% |
| Profit after taxes | € 1,153 | € 13,632 | ▲ € 12,479 |
| Equity | € 11,153 | € 14,785 | ▲ 33% |
| Total debts | € 160,812 | € 264,071 | ▲ 64% |
| Cash | € 82,941 | € 39,338 | ▼ 53% |
| Retained profit | € 1,153 | € 4,785 | ▲ € 3,632 |
| Bank debt | € 100,000 | € 116,641 | ▲ 17% |
| Balance sheet total | € 171,966 | € 278,857 | ▲ 62% |
Key figures of Trimedy, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Trimedy?
What happened at Trimedy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 13,632 (▲ € 12,479 vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Mario Volders became a director. NBB
- Raf Joosen became a director. NBB
In short
From € 1,153 profit in 2024 to € 13,632 profit in 2025.
Paid € 7,229 in corporate taxes since 2024.
Best year ever: 2025, with € 13,632 profit.
A new publication or filing at Trimedy? We notify you, reason included.
Follow TrimedyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Trimedy are Mario Volders and Raf Joosen. Raf Joosen is also behind Joosen-Luyckx, Belki, JOOSEN INVEST, JOOSEN - LUYCKX AQUA BIO and SURGI-TEC.
Directors
According to the 2025 annual accounts
Mario Volders
Director
since 2023
Raf Joosen
Director
Also active at: Joosen-Luyckx, Belki, JOOSEN INVEST, JOOSEN - LUYCKX AQUA BIO, SURGI-TEC, BELGIAN QUALITY FISH, FITNESS SPECIALIST
since 2023
Establishments
Establishment units
Physical locations of this company
Varenpad 6
2370 Arendonk
Poortakkerstraat 43
9051 Gent
Active since 14 December 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1003.419.468
- VAT number
- BE 1003.419.468
- Registered office
- Varenpad 6, 2370 Arendonk
- Names & denominations
- Trimedy
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 December 2023
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Activiteiten van tandartspraktijken